GRIFOLS reported EUR4.54B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 33.76B 3.29B Jun/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
argenx SE USD 46.65B 13.36B Oct/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
Cie Automotive EUR 3.56B 640.97M Dec/2025
Demant DKK 56.79B 10.78B Jun/2026
Ence Energia y Celulosa EUR 555.23M 37.3M Mar/2026
Essilor EUR 80.48B 4.32B Oct/2026
Ferrovial EUR 35.77B 7.23B Oct/2026
Fresenius EUR 22.51B 2.45B Jun/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Inditex EUR 175.9B 18.26B Jun/2026
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Merck EUR 18.98B 27.8B Jun/2026
Novartis USD 266.01B 25.42B Oct/2026
Philips EUR 23.09B 615.44M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
UCB EUR 46.41B 13.94B Dec/2025
Viscofan EUR 2.58B 128.72M Oct/2026